The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/appi.focus.130110

Since the initial description of bipolar disorder (BD), longitudinal observations suggested that episodes are more frequent as the disorder progressed. Staging models in BD consider that there is a subset of patients who present a more severe course of illness with a higher number of episodes and a propensity to treatment resistance. There is an emerging body of knowledge suggesting that staging models may provide clinicians with a useful tool to predict the course of illness and organize treatment strategies to individual patients. The aim of the present work is to review the evidence related to the use of staging models in bipolar disorder.